Renaissance Technologies LLC Has $11.44 Million Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Share on StockTwits

Renaissance Technologies LLC lessened its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 13.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 46,800 shares of the medical instruments supplier’s stock after selling 7,100 shares during the quarter. Renaissance Technologies LLC owned approximately 1.19% of Mesa Laboratories worth $11,435,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Aperio Group LLC acquired a new stake in Mesa Laboratories in the 2nd quarter valued at approximately $27,000. LS Investment Advisors LLC acquired a new stake in Mesa Laboratories in the 2nd quarter valued at approximately $28,000. O Shaughnessy Asset Management LLC acquired a new stake in Mesa Laboratories in the 1st quarter valued at approximately $41,000. Bank of Montreal Can raised its position in Mesa Laboratories by 1,982.4% in the 2nd quarter. Bank of Montreal Can now owns 354 shares of the medical instruments supplier’s stock valued at $86,000 after buying an additional 337 shares during the last quarter. Finally, Quantamental Technologies LLC raised its position in Mesa Laboratories by 61.9% in the 2nd quarter. Quantamental Technologies LLC now owns 489 shares of the medical instruments supplier’s stock valued at $119,000 after buying an additional 187 shares during the last quarter. 90.18% of the stock is currently owned by institutional investors and hedge funds.

MLAB stock traded down $4.30 during mid-day trading on Friday, reaching $249.54. The company had a trading volume of 56,149 shares, compared to its average volume of 65,312. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.59 and a quick ratio of 1.26. The stock has a 50 day simple moving average of $225.93 and a two-hundred day simple moving average of $231.81. The company has a market capitalization of $973.03 million, a price-to-earnings ratio of 44.95 and a beta of 0.32. Mesa Laboratories, Inc. has a 52 week low of $167.34 and a 52 week high of $268.47.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings results on Tuesday, July 30th. The medical instruments supplier reported $1.73 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.59 by $0.14. The firm had revenue of $26.29 million during the quarter, compared to the consensus estimate of $25.70 million. Mesa Laboratories had a return on equity of 19.67% and a net margin of 7.53%. On average, equities analysts predict that Mesa Laboratories, Inc. will post 7.61 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Friday, August 30th were paid a $0.16 dividend. The ex-dividend date was Thursday, August 29th. This represents a $0.64 dividend on an annualized basis and a yield of 0.26%. Mesa Laboratories’s dividend payout ratio is 11.92%.

MLAB has been the topic of a number of recent research reports. Evercore ISI initiated coverage on Mesa Laboratories in a research report on Monday, August 26th. They issued an “outperform” rating and a $250.00 target price on the stock. BidaskClub raised Mesa Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, September 14th. Zacks Investment Research raised Mesa Laboratories from a “sell” rating to a “buy” rating and set a $244.00 target price on the stock in a research report on Wednesday, August 14th. TheStreet raised Mesa Laboratories from a “c+” rating to a “b” rating in a research report on Tuesday, July 30th. Finally, ValuEngine raised Mesa Laboratories from a “hold” rating to a “buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $247.00.

Mesa Laboratories Profile

Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.

Recommended Story: Systematic Risk

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.